Hepatitis C vaccine developed by Indian scientists

Feb-2016

A team of Indian scientists from the Indian Institute of Science (IISc) has developed Hepatitis C vaccine to treat HCV genotype 3a, which is prevalently common in India.
 
The vaccine is primarily customized for Indians, and the preliminary results were found to be promising. The experimental vaccine is one of the several virus-like particle based vaccines that are being developed all over the world.
 
The study was jointly funded by department of biotechnology and Indo-Australian Biotechnology Fund (IABF).
 
The team led by Prof. Saumitra Das has developed a molecular cocktail of bioengineered adenoviral vector laden with virus-like particles that structurally mimics HCV pathogen. The vector vaccine contains envelope and core proteins of HCV without virulence but with antigenicity to achieve immunoprophylaxis.
 
The study results were published in Vaccine. drugsupdate.com